Goldman Sachs’s Silence Therapeutics SLN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-24,375
| Closed | -$68.7K | – | 5346 |
|
|
2025
Q1 | $68.7K | Sell |
24,375
-12,510
| -34% | -$35.3K | ﹤0.01% | 4877 |
|
|
2024
Q4 | $254K | Buy |
36,885
+6,253
| +20% | +$43K | ﹤0.01% | 4585 |
|
|
2024
Q3 | $557K | Buy |
30,632
+14,376
| +88% | +$261K | ﹤0.01% | 4057 |
|
|
2024
Q2 | $309K | Sell |
16,256
-5,483
| -25% | -$104K | ﹤0.01% | 4199 |
|
|
2024
Q1 | $470K | Buy |
+21,739
| New | +$470K | ﹤0.01% | 4015 |
|
|
2023
Q4 | – | Sell |
-266,667
| Closed | -$2.62M | – | 4905 |
|
|
2023
Q3 | $2.62M | Sell |
266,667
-143,333
| -35% | -$1.41M | ﹤0.01% | 2918 |
|
|
2023
Q2 | $2.26M | Sell |
410,000
-250,000
| -38% | -$1.38M | ﹤0.01% | 3132 |
|
|
2023
Q1 | $4.09M | Sell |
660,000
-189
| -0% | -$1.17K | ﹤0.01% | 2680 |
|
|
2022
Q4 | $10.1M | Buy |
660,189
+189
| +0% | +$2.88K | ﹤0.01% | 2131 |
|
|
2022
Q3 | $6.62M | Hold |
660,000
| – | – | ﹤0.01% | 2441 |
|
|
2022
Q2 | $7.82M | Sell |
660,000
-305,815
| -32% | -$3.62M | ﹤0.01% | 2318 |
|
|
2022
Q1 | $18.4M | Buy |
965,815
+205,815
| +27% | +$3.91M | ﹤0.01% | 1771 |
|
|
2021
Q4 | $18.2M | Buy |
+760,000
| New | +$18.2M | ﹤0.01% | 1818 |
|